246 related articles for article (PubMed ID: 11007483)
1. The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo.
Liu Z; Zhou X; Shapiro SD; Shipley JM; Twining SS; Diaz LA; Senior RM; Werb Z
Cell; 2000 Sep; 102(5):647-55. PubMed ID: 11007483
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil elastase cleaves the murine hemidesmosomal protein BP180/type XVII collagen and generates degradation products that modulate experimental bullous pemphigoid.
Lin L; Betsuyaku T; Heimbach L; Li N; Rubenstein D; Shapiro SD; An L; Giudice GJ; Diaz LA; Senior RM; Liu Z
Matrix Biol; 2012 Jan; 31(1):38-44. PubMed ID: 21979170
[TBL] [Abstract][Full Text] [Related]
3. A critical role for neutrophil elastase in experimental bullous pemphigoid.
Liu Z; Shapiro SD; Zhou X; Twining SS; Senior RM; Giudice GJ; Fairley JA; Diaz LA
J Clin Invest; 2000 Jan; 105(1):113-23. PubMed ID: 10619867
[TBL] [Abstract][Full Text] [Related]
4. Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid.
Verraes S; Hornebeck W; Polette M; Borradori L; Bernard P
J Invest Dermatol; 2001 Nov; 117(5):1091-6. PubMed ID: 11710917
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
[TBL] [Abstract][Full Text] [Related]
6. Macrophages, but not T and B lymphocytes, are critical for subepidermal blister formation in experimental bullous pemphigoid: macrophage-mediated neutrophil infiltration depends on mast cell activation.
Chen R; Fairley JA; Zhao ML; Giudice GJ; Zillikens D; Diaz LA; Liu Z
J Immunol; 2002 Oct; 169(7):3987-92. PubMed ID: 12244200
[TBL] [Abstract][Full Text] [Related]
7. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid.
Liu Z; Shipley JM; Vu TH; Zhou X; Diaz LA; Werb Z; Senior RM
J Exp Med; 1998 Aug; 188(3):475-82. PubMed ID: 9687525
[TBL] [Abstract][Full Text] [Related]
8. 92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen.
Ståhle-Bäckdahl M; Inoue M; Guidice GJ; Parks WC
J Clin Invest; 1994 May; 93(5):2022-30. PubMed ID: 8182134
[TBL] [Abstract][Full Text] [Related]
9. Synergy between a plasminogen cascade and MMP-9 in autoimmune disease.
Liu Z; Li N; Diaz LA; Shipley M; Senior RM; Werb Z
J Clin Invest; 2005 Apr; 115(4):879-87. PubMed ID: 15841177
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin.
Sitaru C; Schmidt E; Petermann S; Munteanu LS; Bröcker EB; Zillikens D
J Invest Dermatol; 2002 Apr; 118(4):664-71. PubMed ID: 11918714
[TBL] [Abstract][Full Text] [Related]
11. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.
Feldrihan V; Licarete E; Florea F; Cristea V; Popescu O; Sitaru C; Chiriac MT
Hum Immunol; 2014 Apr; 75(4):354-63. PubMed ID: 24468586
[TBL] [Abstract][Full Text] [Related]
12. Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5aR2.
Karsten CM; Beckmann T; Holtsche MM; Tillmann J; Tofern S; Schulze FS; Heppe EN; Ludwig RJ; Zillikens D; König IR; Köhl J; Schmidt E
Front Immunol; 2018; 9():488. PubMed ID: 29599777
[TBL] [Abstract][Full Text] [Related]
13. Dual targets for mouse mast cell protease-4 in mediating tissue damage in experimental bullous pemphigoid.
Lin L; Bankaitis E; Heimbach L; Li N; Abrink M; Pejler G; An L; Diaz LA; Werb Z; Liu Z
J Biol Chem; 2011 Oct; 286(43):37358-67. PubMed ID: 21880713
[TBL] [Abstract][Full Text] [Related]
14. Monocytes enhance neutrophil-induced blister formation in an ex vivo model of bullous pemphigoid.
de Graauw E; Sitaru C; Horn MP; Borradori L; Yousefi S; Simon D; Simon HU
Allergy; 2018 May; 73(5):1119-1130. PubMed ID: 29222810
[TBL] [Abstract][Full Text] [Related]
15. Bullous pemphigoid: using animal models to study the immunopathology.
Liu Z
J Investig Dermatol Symp Proc; 2004 Jan; 9(1):41-6. PubMed ID: 14870984
[TBL] [Abstract][Full Text] [Related]
16. Repetitive immunization breaks tolerance to type XVII collagen and leads to bullous pemphigoid in mice.
Hirose M; Recke A; Beckmann T; Shimizu A; Ishiko A; Bieber K; Westermann J; Zillikens D; Schmidt E; Ludwig RJ
J Immunol; 2011 Aug; 187(3):1176-83. PubMed ID: 21705619
[TBL] [Abstract][Full Text] [Related]
17. Cloning of hamster type XVII collagen cDNA, and pathogenesis of anti-type XVII collagen antibody and complement in hamster bullous pemphigoid.
Yamamoto K; Inoue N; Masuda R; Fujimori A; Saito T; Imajoh-Ohmi S; Shinkai H; Sakiyama H
J Invest Dermatol; 2002 Mar; 118(3):485-92. PubMed ID: 11874488
[TBL] [Abstract][Full Text] [Related]
18. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180.
Liu Z; Diaz LA; Troy JL; Taylor AF; Emery DJ; Fairley JA; Giudice GJ
J Clin Invest; 1993 Nov; 92(5):2480-8. PubMed ID: 7693763
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticosteroids differentially regulate MMP-9 and neutrophil elastase in COPD.
Vlahos R; Wark PA; Anderson GP; Bozinovski S
PLoS One; 2012; 7(3):e33277. PubMed ID: 22413009
[TBL] [Abstract][Full Text] [Related]
20. The role of complement in experimental bullous pemphigoid.
Liu Z; Giudice GJ; Swartz SJ; Fairley JA; Till GO; Troy JL; Diaz LA
J Clin Invest; 1995 Apr; 95(4):1539-44. PubMed ID: 7706459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
